Keywords: promising, results, alnylam, amd, rnai, treatment, usa-based

Promising results for Alnylam's AMD RNAi treatment

Article | 07 March 2005

Print This

USA-based RNAi therapeutics company Alnylam Pharmaceuticals has posted encouraging in vivo efficacy data on the use of its RNA interference ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in